Skip to product information
1. Regulatory Status: Yunnan Baiyao products are not recognized as safe and effective by regulatory agencies like the FDA and EMA. They are classified as dietary supplements or new drugs, lacking approval for specific medical uses such as wound treatment or pain relief. 2. Hemostatic Effects: Yunnan Baiyao demonstrates effectiveness in stopping blood flow when applied topically to wounds, suggesting potential hemostatic properties. 3. Limited Oral Efficacy: Oral administration shows minimal results in laboratory tests, with some theoretical benefits suggested for conditions like rheumatoid arthritis. However, the significance of these findings remains uncertain. 4. Potential for Cancer Treatment: In vitro studies indicate that Yunnan Baiyao may induce cell death in hemangiosarcoma, a type of canine cancer. It is reported to be well-tolerated in dogs, but high-quality evidence supporting its use is lacking. 5. Clinical Effects: Double-blind studies have shown that Yunnan Baiyao administration can reduce intraoperative bleeding in certain surgical procedures, as well as decrease facial swelling. However, concerns persist regarding quality control, manufacturing regulations, and standardization in China.
(5 Pack) 16 Caps each (80 ct.) Capsules C32080
Sale price
$14.90
Regular price $55.37
Shipping calculated at checkout.